Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Capital Expenditure

-$139.50M

TTM · Period ending: · USD

BIO logo

BIO Capital Expenditure

Latest reported-$139.50M
BIO TTM CapEx (-$13.40M → -$139.50M)
High-resolution chart · PNG

BIO capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-139,500,000
-153,200,000
-157,600,000
-154,704,000
-186,643,000
-183,224,000
-189,000,000
-188,341,000
-168,773,000
-161,131,000
-156,680,000
-161,368,000
-144,872,000
-127,567,000
-124,920,000
-121,227,000
-128,280,000
-134,334,000
-120,803,000
-116,698,000
-102,048,000
-96,776,000
-98,920,000
-81,383,000
-92,496,000
-96,594,000
-98,532,000
-130,808,000
-121,771,000
-126,273,000
-129,828,000
-102,027,000
-100,156,000
-102,979,000
-115,127,000
-134,296,000
-153,571,000
-155,607,000
-141,571,000
-124,313,000
-109,653,000
-110,281,000
-113,372,000
-125,513,000
-128,176,000
-129,926,000
-136,478,000
-126,195,000
-119,074,000
-109,653,000
-109,280,000
-119,545,000
-136,365,000
-153,864,000
-154,197,000
-149,742,000
-137,554,000
-120,311,000
-103,324,000
-100,544,000
-96,648,000
-91,675,000
-91,853,000
-78,981,000
-75,511,000
-75,784,000
-76,361,000
-79,041,000
-87,305,000
-87,756,000
-88,809,000
-80,786,000
-73,584,000
-71,079,000
-62,670,000
-62,921,000
-57,481,000
-52,980,000
-52,987,000
-47,837,000
-43,315,000
-37,599,000
-36,055,000
-45,163,000
-49,027,000
-56,850,000
-60,493,000
-62,959,000
-72,692,000
-71,439,000
-69,003,000
-58,637,000
-48,618,000
-44,762,000
-42,224,000
-42,416,000
-42,551,000
-42,393,000
-43,228,000
-39,535,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.